Fox Run Management L.L.C. acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 20,761 shares of the company's stock, valued at approximately $482,000.
A number of other hedge funds have also recently made changes to their positions in OPCH. Cornerstone Investment Partners LLC lifted its position in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after acquiring an additional 333 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Assetmark Inc. lifted its holdings in shares of Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after purchasing an additional 487 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after buying an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management grew its holdings in Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after buying an additional 550 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Stock Performance
Option Care Health stock traded down $0.47 during mid-day trading on Friday, reaching $34.73. The company's stock had a trading volume of 1,378,809 shares, compared to its average volume of 1,713,822. The firm's fifty day moving average price is $32.47 and its two-hundred day moving average price is $28.41. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a market capitalization of $5.70 billion, a P/E ratio of 29.18, a PEG ratio of 2.30 and a beta of 1.33.
Insider Activity
In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is owned by company insiders.
Analysts Set New Price Targets
A number of equities analysts have issued reports on OPCH shares. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective for the company. JMP Securities restated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, Barrington Research upped their price objective on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $33.00.
Get Our Latest Stock Analysis on Option Care Health
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
